ZCA
BPMC
Zeke Capital Advisors’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,023
| Closed | -$254K | – | 474 |
|
|
2022
Q2 | $254K | Hold |
5,023
| – | – | 0.02% | 381 |
|
|
2022
Q1 | $321K | Buy |
5,023
+1,323
| +36% | +$84.5K | 0.02% | 352 |
|
|
2021
Q4 | $396K | Sell |
3,700
-142
| -4% | -$15.2K | 0.02% | 189 |
|
|
2021
Q3 | $395K | Hold |
3,842
| – | – | 0.02% | 175 |
|
|
2021
Q2 | $338K | Buy |
3,842
+485
| +14% | +$42.7K | 0.02% | 189 |
|
|
2021
Q1 | $326K | Buy |
3,357
+1,330
| +66% | +$129K | 0.02% | 183 |
|
|
2020
Q4 | $227K | Sell |
2,027
-245
| -11% | -$27.4K | 0.02% | 242 |
|
|
2020
Q3 | $211K | Buy |
+2,272
| New | +$211K | 0.02% | 208 |
|
|
2020
Q1 | – | Sell |
-9,526
| Closed | -$763K | – | 274 |
|
|
2019
Q4 | $763K | Buy |
9,526
+2,288
| +32% | +$183K | 0.06% | 273 |
|
|
2019
Q3 | $532K | Buy |
7,238
+1,915
| +36% | +$141K | 0.05% | 345 |
|
|
2019
Q2 | $502K | Buy |
5,323
+1,407
| +36% | +$133K | 0.05% | 355 |
|
|
2019
Q1 | $313K | Sell |
3,916
-7,998
| -67% | -$639K | 0.03% | 462 |
|
|
2018
Q4 | $642K | Buy |
11,914
+3,614
| +44% | +$195K | 0.06% | 287 |
|
|
2018
Q3 | $648K | Buy |
+8,300
| New | +$648K | 0.05% | 334 |
|
|
2018
Q2 | – | Sell |
-2,253
| Closed | -$207K | – | 644 |
|
|
2018
Q1 | $207K | Buy |
+2,253
| New | +$207K | 0.02% | 562 |
|